These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31558125)

  • 1. Efficacy and safety of trimethoprim-sulfamethoxazole in HIV-infected patients with cerebral toxoplasmosis in Brazil: a single-arm open-label clinical trial.
    Pellegrino D; Gryschek R; de Oliveira ACP; Marcusso R; Correia A; Vidal JE
    Int J STD AIDS; 2019 Oct; 30(12):1156-1162. PubMed ID: 31558125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Epidemiologic characteristics of cerebral toxoplasmosis in 399 HIV-infected patients followed between 1983 and 1994].
    Bossi P; Caumes E; Astagneau P; Li TS; Paris L; Mengual X; Katlama C; Bricaire F
    Rev Med Interne; 1998 May; 19(5):313-7. PubMed ID: 9775164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study of treatment of cerebral toxoplasmosis in AIDS patients with trimethoprim-sulphamethoxazole.
    Torre D; Speranza F; Martegani R; Zeroli C; Banfi M; Airoldi M
    J Infect; 1998 Jul; 37(1):15-8. PubMed ID: 9733371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy and good tolerance of cotrimoxazole as treatment of cerebral toxoplasmosis in AIDS].
    Smadja D; Fournerie P; Cabre P; Cabie A; Olindo S
    Presse Med; 1998 Sep; 27(26):1315-20. PubMed ID: 9779045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cerebral toxoplasmosis in AIDS: efficacy and good tolerance of cotrimoxazole].
    Smadja D; Lin L; Cidolit E; Neisson-Vernant C; Cabre P; Vernant JC
    Presse Med; 1994 May; 23(19):907. PubMed ID: 7937621
    [No Abstract]   [Full Text] [Related]  

  • 6. A systematic review and meta-analysis of the relative efficacy and safety of treatment regimens for HIV-associated cerebral toxoplasmosis: is trimethoprim-sulfamethoxazole a real option?
    Hernandez AV; Thota P; Pellegrino D; Pasupuleti V; Benites-Zapata VA; Deshpande A; Penalva de Oliveira AC; Vidal JE
    HIV Med; 2017 Feb; 18(2):115-124. PubMed ID: 27353303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolized pentamidine, cotrimoxazole and dapsone-pyrimethamine for primary prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Antinori A; Murri R; Ammassari A; De Luca A; Linzalone A; Cingolani A; Damiano F; Maiuro G; Vecchiet J; Scoppettuolo G
    AIDS; 1995 Dec; 9(12):1343-50. PubMed ID: 8605054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of toxoplasmic encephalitis in HIV-infected adults (with an emphasis on resource-poor settings).
    Dedicoat M; Livesley N
    Cochrane Database Syst Rev; 2006 Jul; (3):CD005420. PubMed ID: 16856096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxoplasmic encephalitis in HIV-infected persons: risk factors and trends. The Adult/Adolescent Spectrum of Disease Group.
    Jones JL; Hanson DL; Chu SY; Ciesielski CA; Kaplan JE; Ward JW; Navin TR
    AIDS; 1996 Oct; 10(12):1393-9. PubMed ID: 8902069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral trimethoprim-sulfamethoxazole in the treatment of cerebral toxoplasmosis in AIDS patients--a prospective study.
    Francis P; Patel VB; Bill PL; Bhigjee AI
    S Afr Med J; 2004 Jan; 94(1):51-3. PubMed ID: 14971234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of cerebral toxoplasmosis in AIDS with cotrimoxazole].
    Finielz P; Chuet C; Ramdane M; Guiserix J
    Presse Med; 1995 May; 24(19):917. PubMed ID: 7638140
    [No Abstract]   [Full Text] [Related]  

  • 12. Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
    Smith CL; Brown I; Torraca BM
    Clin Infect Dis; 1997 Dec; 25(6):1477-8. PubMed ID: 9431404
    [No Abstract]   [Full Text] [Related]  

  • 13. A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections.
    Li Y; Zeng YM; Lu YQ; Qin YY; Chen YK
    Medicine (Baltimore); 2020 May; 99(20):e20146. PubMed ID: 32443329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Bucher HC; Griffith L; Guyatt GH; Opravil M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):104-14. PubMed ID: 9241108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cotrimoxazole is effective as primary prophylaxis for toxoplasmic encephalitis in HIV-infected patients: a case control study.
    Weigel HM; de Vries E; Regez RM; Henrichs JH; Ten Velden JJ; Frissen PH; van der Meer JT
    Scand J Infect Dis; 1997; 29(5):499-502. PubMed ID: 9435040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute encephalopathy caused by sulfadiazine and trimethoprim-sulfamethoxazole in a patient with AIDS].
    Arjol AM; Sánchez C; Dalmau D
    Enferm Infecc Microbiol Clin; 1998 May; 16(5):250-1. PubMed ID: 9666594
    [No Abstract]   [Full Text] [Related]  

  • 17. Desensitization to trimethoprim-sulfamethoxazole in a toxoplasmic encephalitis patient who was intolerant to conventional treatments.
    Miyata N; Yoshimura Y; Hikosaka K; Norose K; Tachikawa N
    J Infect Chemother; 2020 Mar; 26(3):289-293. PubMed ID: 31711832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restarting trimethoprim-sulfamethoxazole after a hypersensitivity reaction in patients infected with the human immunodeficiency virus.
    Everson-Mays RE; Weidle PJ
    Am J Health Syst Pharm; 1997 Jul; 54(13):1545-50. PubMed ID: 9217946
    [No Abstract]   [Full Text] [Related]  

  • 19. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case report of eosinophilic meningitis associated with cerebral toxoplasmosis in an HIV-positive patient.
    Vidal JE; Cunha MA; Kassab MJ; Dauar RF; Vasconcelos DM
    Int J STD AIDS; 2020 May; 31(6):596-599. PubMed ID: 32264778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.